These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 9337376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela.
    Hoshino Y, Wagner M, Yan XY, Perez-Schael I, Kapikian AZ.
    J Infect Dis; 2003 Mar 01; 187(5):791-800. PubMed ID: 12599053
    [Abstract] [Full Text] [Related]

  • 4. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ.
    Am J Dis Child; 1990 Mar 01; 144(3):285-9. PubMed ID: 2154925
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.
    Vaccine; 2006 May 29; 24(22):4821-9. PubMed ID: 16621194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC, Gabbay YB, Mascarenhas JD, de Freitas RB, Oliveira CS, Bellesi N, Monteiro TA, Lins-Lainson Z, Ramos FL, Valente SA.
    Bull World Health Organ; 1996 May 29; 74(5):491-500. PubMed ID: 9002329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI.
    Semin Pediatr Infect Dis; 2006 Oct 29; 17(4):188-94. PubMed ID: 17055369
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I, Rojas Mazzei AM, Flores J.
    Acta Cient Venez; 1991 Oct 29; 42(6):296-312. PubMed ID: 1668865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF, Black RE, Flores J, Lazo F, Butron B, Linares A, Huapaya A, Ventura G, Gil A, Kapikian AZ.
    Vaccine; 1996 Feb 29; 14(3):237-43. PubMed ID: 8920706
    [Abstract] [Full Text] [Related]

  • 20. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.
    Pediatr Infect Dis J; 2006 Feb 29; 25(2):118-22. PubMed ID: 16462287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.